When Japan scaled back its vaccine programs in response to safety concerns and public skepticism, the results provide a data-rich natural experiment in what happens when immunization rates drop—and the findings aren't encouraging.
The Nature analysis examines several Japanese vaccine policy shifts over recent decades, offering lessons particularly relevant as vaccine hesitancy rises globally.
Japan's experience includes some notable examples:
HPV vaccine suspension: In 2013, Japan suspended active recommendation of the HPV vaccine following reports of adverse events. While the vaccine remained technically available, the loss of government recommendation caused uptake to plummet from around 70% to below 1%.
The result? Japan now faces significantly higher rates of cervical cancer in cohorts that missed vaccination compared to countries that maintained their programs. The reported adverse events that triggered the suspension have not been definitively linked to the vaccine in subsequent research, suggesting the policy response may have been disproportionate to the actual risk.
Measles vaccination gaps: Japan also experienced periods of reduced measles vaccination coverage, leading to outbreaks that required subsequent catch-up programs to control.
What makes Japan's experience valuable for policy analysis is the quality of their health data. Japan maintains excellent disease surveillance and health records, allowing researchers to draw relatively clear causal connections between vaccination rate changes and disease outcomes.
The key insight isn't particularly surprising, but it is quantified: when vaccination rates drop below herd immunity thresholds, disease incidence rises in predictable ways. What's less obvious is how difficult it can be to restore public confidence once it's damaged.
Japan only resumed active HPV vaccine recommendation in 2022—nine years after the suspension—despite accumulating evidence of safety. That's nearly a decade of cohorts with low vaccination coverage, translating to increased cancer burden for years to come.
The policy implications extend beyond Japan. The article appears in Nature at a moment when vaccine hesitancy is rising in multiple countries, driven by various factors including social media misinformation, political polarization, and erosion of trust in public health institutions.
